Better Buy: SpaceX or Nvidia?

Article argues Nvidia (NVDA) is the better buy versus SpaceX, citing expected revenue growth of 82% this year vs SpaceX’s ~33% overall 2025 growth (8% space, 50% connectivity, 22% xAI). It highlights valuation disparity: SpaceX generated $18.7B revenue in 2025 but is valued at a ~$1.57T market cap (~84x P/S), far above Nvidia’s 31x trailing and 23x forward P/E. Overall takeaway is mixed-to-cautious on SpaceX (non-profitable, high premium) while leaning toward Nvidia as more reasonably priced.

Analysis

The key market mechanism here is not “space vs chips,” but cash-flow visibility versus narrative value. NVDA is a public, earnings-driven compounding story that the market can underwrite every quarter; SPCX is a bundled private-market claim on several unrelated economics, which usually earns a discount once capital is no longer free. In other words, “diversification” inside a late-stage private vehicle is not automatically a premium if the underlying segments have different cycle lengths and different funding needs.

For NVDA, the near-term issue is not demand existence but digestion: if hyperscaler capex pauses, the stock can de-rate quickly even if the secular AI trend remains intact. That makes the next 1-3 months an earnings-and-guidance trade, while the 6-18 month debate is whether growth normalizes enough to compress the multiple from “scarcity” to “quality.” The article is directionally right that NVDA is the cleaner public-market expression of AI spend, but the upside is more about valuation support than explosive re-rating from here.

Contrarianly, the market may be underestimating how much of SPCX’s implied premium depends on illiquidity and access rather than verifiable public financials. Starlink can be the stabilizer, but launch, hardware, and xAI are not the same business and do not deserve the same multiple; bundling them can hide risk instead of reducing it. The biggest falsifier for the NVDA thesis is a sequential slowdown in AI infrastructure budgets, not a headline competitor launch.

Key Decisions for Investors

• Buy NVDA on 3-5% pullbacks rather than chasing strength; target a 1-3 month hold into the next earnings cycle. Risk/reward is attractive as long as revenue guide and gross margin hold within consensus bands.
• If already long semis, rotate incremental exposure toward NVDA and away from lower-quality AI beta until hyperscaler capex commentary confirms a second-half re-acceleration.
• Do not force a direct trade in SPCX unless you have primary/secondary access. If you do, require a meaningful discount to the last private mark and a fresh financing print before committing capital.
• Set an alert on NVDA next-quarter revenue guidance and hyperscaler capex revisions; a sequential step-down would be the earliest high-conviction signal to reduce exposure.